SCHEMBL20037551

SCHEMBL20037551

CC(C)c1ccc(CN2CCCC(O)C2)cn1

nearest known ligand 0.55

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.55
▸ HSP90AA1 P07900 1/20 0.48
▸ HTT P42858 1/20 0.46
▸ LTA4H P09960 3/20 0.43
▸ KDM4E B2RXH2 2/20 0.42
▸ TSHR P16473 1/20 0.42
▸ POLB P06746 1/20 0.42
▸ HPGD P15428 1/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.42
▸ CDK4 P11802 1/20 0.42
▸ CDK6 Q00534 1/20 0.42
▸ CHEK1 O14757 1/20 0.42
▸ ACHE P22303 1/20 0.42
▸ MCHR1 Q99705 2/20 0.41
▸ CHRM1 P11229 1/20 0.41
▸ HTR2A P28223 1/20 0.41
▸ GRM2 Q14416 1/20 0.41
▸ CCR5 P51681 1/20 0.40
▸ CNR2 P34972 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20037681 0.86 PRMT5 (0.42) LTA4H
SCHEMBL20203580 0.84 ALDH1A1 (0.50) ALDH1A1LTA4HKDM4EPOLBACHE
SCHEMBL18291394 0.83 ALDH1A1 (0.58) ALDH1A1HSP90AA1HTTLTA4HKDM4E
SCHEMBL20038553 0.83 ALDH1A1 (0.58) ALDH1A1HSP90AA1HTTLTA4HKDM4E
SCHEMBL4547913 0.82 HRH3 (0.50) ALDH1A1KDM4ETSHR
SCHEMBL12028959 0.82 HRH3 (0.47) ALDH1A1KDM4E
SCHEMBL25896863 0.81 HRH3 (0.53) ALDH1A1KDM4ETSHR
SCHEMBL18291757 0.80 ALDH1A1 (0.58) ALDH1A1HTTLTA4HKDM4ETSHR
SCHEMBL12041186 0.80 HRH3 (0.45) LTA4HCHEK1
SCHEMBL20037663 0.80 ALDH1A1 (0.58) ALDH1A1HTTLTA4HKDM4ETSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3305785-A1 PYRIDO[3,4-d]PYRIMIDINE DERIVATIVE AND PHARMACEUTICALLY ACCEPTABLE SALT THEREOF Teijin Pharma Limited (JP) 2018-04-11 — — EP disclosed
Send feedback